v3.26.1
Nature of Operations and Basis of Presentation (Additional Information) (Details)
$ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Sep. 25, 2025
USD ($)
shares
Apr. 03, 2025
Jan. 31, 2026
USD ($)
shares
Dec. 31, 2024
USD ($)
shares
Mar. 31, 2026
USD ($)
Segments
Mar. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
shares
Jan. 20, 2026
USD ($)
shares
Nov. 25, 2025
USD ($)
shares
Description of Organization and Business Operations (Details) [Line Items]                    
Number of Reportable Segments | Segments         1          
Deemed dividend         $ 43,800          
Allowances for expected credit losses accounts receivable         0   $ 0      
Allowances for prompt payment discounts         300   $ 400      
Description of Stockholders' Equity, Reverse Stock Split   the Board of Directors of the Company (the “Board”) approved a reverse stock split of the Common Stock at a ratio of 1-for-35 (the “Reverse Stock Split”), which was effected on April 15, 2025. As a result of the Reverse Stock Split, every 35 shares of pre-Reverse Stock Split Common Stock was combined into one share of post-Reverse Stock Split Common Stock, without any change in par value per share. No fractional shares were issued as a result of the Reverse Stock Split, as fractional shares of Common Stock were rounded down to the nearest whole share.                
Revenue recognized         $ 4,447 $ 1,384        
Voting Stock Outstanding Percentage         21.00%          
Sales discount percentage         2.00%          
Company's ownership percentage         21.00%          
Datavault Securities Purchase Agreement [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Carrying value of the Company's investment                   $ 141,900
Convertible Debt [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Debt, Weighted Average Interest Rate         10.60%   12.35%      
iLeukon Intellectual Property License Agreement [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Carrying value of the Company's investment         $ 1,100          
Outstanding equity       2.00%       2.00%    
Common stock aggregate purchase price       $ 1,100       $ 1,100    
Contingent Payment       $ 1,000       $ 1,000    
Revenue recognized         $ 1,100          
Customer Concentration Risk [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Percentage of net revenue, sole distributor         10.00%          
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Three Customers [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Concentration risk percentage         95.00%          
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Minimum [Member] | Three Customers [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Concentration risk percentage         13.00%          
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Maximum [Member] | Three Customers [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Concentration risk percentage         28.00%          
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Three Customers [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Concentration risk percentage         86.00%   89.00%      
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Minimum [Member] | Four Customer [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Concentration risk percentage         6.00%          
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Minimum [Member] | Three Customers [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Concentration risk percentage         18.00%          
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Maximum [Member] | Four Customer [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Concentration risk percentage         31.00%          
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Maximum [Member] | Three Customers [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Concentration risk percentage         37.00%          
Vivasor Secondary Stock Purchase [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Company's ownership percentage         50.00%          
Agreed to purchase Stock | shares     355,919              
Cash consideration     $ 1,050,000              
Preferred stock, shares issued | shares                 254,228  
Shares amount                 $ 800  
Acea Therapeutics [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Company's ownership percentage         50.00%          
Consulting Fees           700        
Common Stock [Member] | iLeukon Intellectual Property License Agreement [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Number of shares purchase | shares       400,000       400,000    
Datavault Common Stock [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Carrying value of the Company's investment         $ 79,100 $ 79,100        
Datavault Common Stock [Member] | Datavault Securities Purchase Agreement [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Number of shares purchase | shares 15,000,000                  
Common stock aggregate purchase price $ 150,000                  
Pre-Funded Warrant [Member] | Datavault Securities Purchase Agreement [Member]                    
Description of Organization and Business Operations (Details) [Line Items]                    
Number of shares purchase | shares 263,914,094                 263,914,094